Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review

BACKGROUND: Real-world comparisons of biologic treatment outcomes for ulcerative colitis (UC) or Crohn’s disease (CD) patients are limited. We sought to evaluate the real-world effectiveness of vedolizumab (VDZ) and anti-tumor necrosis factor alpha (anti-TNFα) in UC and CD patients in Germany. METHO...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Gastroenterol
Main Authors: Helwig, Ulf, Mross, Michael, Schubert, Stefan, Hartmann, Heinz, Brandes, Alina, Stein, Dara, Kempf, Christian, Knop, Jana, Campbell-Hill, Sarah, Ehehalt, Robert
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2020
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7341567/
https://ncbi.nlm.nih.gov/pubmed/32640990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01332-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker